These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
314 related items for PubMed ID: 29618179
1. Non-Benzoquinone Geldanamycin Analog, WK-88-1, Induces Apoptosis in Human Breast Cancer Cell Lines. Zhao YR, Li HM, Zhu M, Li J, Ma T, Huo Q, Hong YS, Wu CZ. J Microbiol Biotechnol; 2018 Apr 28; 28(4):542-550. PubMed ID: 29618179 [Abstract] [Full Text] [Related]
2. SNX-2112, a novel Hsp90 inhibitor, induces G2/M cell cycle arrest and apoptosis in MCF-7 cells. Wang SX, Ju HQ, Liu KS, Zhang JX, Wang X, Xiang YF, Wang R, Liu JY, Liu QY, Xia M, Xing GW, Liu Z, Wang YF. Biosci Biotechnol Biochem; 2011 Apr 28; 75(8):1540-5. PubMed ID: 21821931 [Abstract] [Full Text] [Related]
3. Non-benzoquinone geldanamycin analogs trigger various forms of death in human breast cancer cells. Zhang Z, Li HM, Zhou C, Li Q, Ma L, Zhang Z, Sun Y, Wang L, Zhang X, Zhu B, Hong YS, Wu CZ, Liu H. J Exp Clin Cancer Res; 2016 Sep 22; 35(1):149. PubMed ID: 27658586 [Abstract] [Full Text] [Related]
4. Induction of Fas-mediated extrinsic apoptosis, p21WAF1-related G2/M cell cycle arrest and ROS generation by costunolide in estrogen receptor-negative breast cancer cells, MDA-MB-231. Choi YK, Seo HS, Choi HS, Choi HS, Kim SR, Shin YC, Ko SG. Mol Cell Biochem; 2012 Apr 22; 363(1-2):119-28. PubMed ID: 22147197 [Abstract] [Full Text] [Related]
5. ERK-modulated intrinsic signaling and G(2)/M phase arrest contribute to the induction of apoptotic death by allyl isothiocyanate in MDA-MB-468 human breast adenocarcinoma cells. Tsai SC, Huang WW, Huang WC, Lu CC, Chiang JH, Peng SF, Chung JG, Lin YH, Hsu YM, Amagaya S, Yang JS. Int J Oncol; 2012 Dec 22; 41(6):2065-72. PubMed ID: 23008020 [Abstract] [Full Text] [Related]
6. Synthesis and biological evaluation of geldanamycin analogs against human cancer cells. Li YP, Chen JJ, Shen JJ, Cui J, Wu LZ, Wang Z, Li ZR. Cancer Chemother Pharmacol; 2015 Apr 22; 75(4):773-82. PubMed ID: 25681003 [Abstract] [Full Text] [Related]
7. Combined effect of Hsp90 inhibitor geldanamycin and parthenolide via reactive oxygen species-mediated apoptotic process on epithelial ovarian cancer cells. Lee CS, Kim YJ, Lee SA, Myung SC, Kim W. Basic Clin Pharmacol Toxicol; 2012 Sep 22; 111(3):173-81. PubMed ID: 22433057 [Abstract] [Full Text] [Related]
8. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft. Saxena R, Fatima I, Chandra V, Blesson CS, Kharkwal G, Hussain MK, Hajela K, Roy BG, Dwivedi A. Steroids; 2013 Nov 22; 78(11):1071-86. PubMed ID: 23891847 [Abstract] [Full Text] [Related]
9. Pyoluteorin induces cell cycle arrest and apoptosis in human triple-negative breast cancer cells MDA-MB-231. Ding T, Yang LJ, Zhang WD, Shen YH. J Pharm Pharmacol; 2020 Jul 22; 72(7):969-978. PubMed ID: 32246778 [Abstract] [Full Text] [Related]
10. Heat shock protein 90 inhibitors: new mode of therapy to overcome endocrine resistance. Wong C, Chen S. Cancer Res; 2009 Nov 15; 69(22):8670-7. PubMed ID: 19861537 [Abstract] [Full Text] [Related]
11. 2-Methoxy-5((3,4,5-trimethosyphenyl)seleninyl) phenol (SQ0814061), a novel microtubule inhibitor, evokes G2/M cell cycle arrest and apoptosis in human breast cancer cells. Xu J, Zuo D, Qi H, Shen Q, Bai Z, Han M, Li Z, Zhang W, Wu Y. Biomed Pharmacother; 2016 Mar 15; 78():308-321. PubMed ID: 26898456 [Abstract] [Full Text] [Related]
12. Discovery of 3-phenylquinolinylchalcone derivatives as potent and selective anticancer agents against breast cancers. Tseng CH, Tzeng CC, Hsu CY, Cheng CM, Yang CN, Chen YL. Eur J Med Chem; 2015 Jun 05; 97():306-19. PubMed ID: 26005780 [Abstract] [Full Text] [Related]
13. Small molecule inhibitor screening identifified HSP90 inhibitor 17-AAG as potential therapeutic agent for gallbladder cancer. Weber H, Valbuena JR, Barbhuiya MA, Stein S, Kunkel H, García P, Bizama C, Riquelme I, Espinoza JA, Kurtz SE, Tyner JW, Calderon JF, Corvalán AH, Grez M, Pandey A, Leal-Rojas P, Roa JC. Oncotarget; 2017 Apr 18; 8(16):26169-26184. PubMed ID: 28412732 [Abstract] [Full Text] [Related]
14. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells. Li JP, Yang YX, Liu QL, Pan ST, He ZX, Zhang X, Yang T, Chen XW, Wang D, Qiu JX, Zhou SF. Drug Des Devel Ther; 2015 Apr 18; 9():1627-52. PubMed ID: 25834401 [Abstract] [Full Text] [Related]
15. Anticancer effects of the Hsp90 inhibitor 17-demethoxy-reblastatin in human breast cancer MDA-MB-231 cells. Zhao Q, Wu CZ, Lee JK, Zhao SR, Li HM, Huo Q, Ma T, Zhang J, Hong YS, Liu H. J Microbiol Biotechnol; 2014 Jul 18; 24(7):914-20. PubMed ID: 24705874 [Abstract] [Full Text] [Related]
16. Debio-0932, a second generation oral Hsp90 inhibitor, induces apoptosis in MCF-7 and MDA-MB-231 cell lines. Özgür A, Kara A, Gökşen Tosun N, Tekin Ş, Gökçe İ. Mol Biol Rep; 2021 Apr 18; 48(4):3439-3449. PubMed ID: 33999319 [Abstract] [Full Text] [Related]
17. 12-Deoxyphorbol 13-palmitate mediated cell growth inhibition, G2-M cell cycle arrest and apoptosis in BGC823 cells. Xu HY, Chen ZW, Li H, Zhou L, Liu F, Lv YY, Liu JC. Eur J Pharmacol; 2013 Jan 30; 700(1-3):13-22. PubMed ID: 23220710 [Abstract] [Full Text] [Related]
18. 3-(3-Hydroxy-4-methoxyphenyl)-4-(3,4,5-trimethoxyphenyl)-1,2,5-selenadiazole (G-1103), a novel combretastatin A-4 analog, induces G2/M arrest and apoptosis by disrupting tubulin polymerization in human cervical HeLa cells and fibrosarcoma HT-1080 cells. Zuo D, Guo D, Jiang X, Guan Q, Qi H, Xu J, Li Z, Yang F, Zhang W, Wu Y. Chem Biol Interact; 2015 Feb 05; 227():7-17. PubMed ID: 25529822 [Abstract] [Full Text] [Related]
19. Hypoxia attenuates Hsp90 inhibitor 17-DMAG-induced cyclin B1 accumulation in hepatocellular carcinoma cells. Zhang J, Li H, Huang Z, He Y, Zhou X, Huang T, Dai P, Duan D, Ma X, Yin Q, Wang X, Liu H, Chen S, Zou F, Chen X. Cell Stress Chaperones; 2016 Mar 05; 21(2):339-48. PubMed ID: 26786409 [Abstract] [Full Text] [Related]
20. Anti-tumor activity of SL4 against breast cancer cells: induction of G2/M arrest through modulation of the MAPK-dependent p21 signaling pathway. Wang LH, Jiang XR, Chen GL, Guo W, Zhang JY, Cui LJ, Li HH, Li M, Liu X, Yang JY, Wu CF. Sci Rep; 2016 Nov 07; 6():36486. PubMed ID: 27819344 [Abstract] [Full Text] [Related] Page: [Next] [New Search]